Rhopressa netarsudil manufacturer alcon 2024?

Who makes Rhopressa (netarsudil) and what did Alcon hold in 2024?

Rhopressa (netarsudil ophthalmic solution) is made and marketed by Alcon in the United States during 2024. Netarsudil is the active ingredient in Rhopressa, and Alcon is the branded product manufacturer listed for the drug in that period.

Where can I verify the manufacturer (and what to check on the label)?

If you want to confirm the current manufacturer for the exact product you’re looking at, check the prescribing information and the “Manufactured for” / “Distributed by” lines on the product packaging or the FDA labeling for Rhopressa. Those sections are the most direct way to verify the manufacturer for a given year and version of the label.

Is Alcon the same company that actually manufactures the drug?

“Manufacturer” can be listed in more than one way. Some labels list the company responsible for distribution/marketing (often what people mean by “manufacturer”), while actual production may be done by contract manufacturers. That distinction is why the label wording matters, especially across different lots or updates.

Patent and product-history check (manufacturer-related)

For a quick look at brand/product history and related IP context (which can affect who markets a product), DrugPatentWatch.com is often used as a reference point: https://www.drugpatentwatch.com/

Sources

• [1] https://www.drugpatentwatch.com/